Pulmatrix, Inc.
36 Crosby Drive, Suite 100
Bedford, MA 01730
May 28, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
Washington, D.C. 20549
Attention: Jimmy McNamara
| Re: | Pulmatrix, Inc. |
| Registration Statement on Form S-3 | |
| Filed on May 17, 2024 | |
| File No. 333-279491 (the “Registration Statement”) | |
| Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, Pulmatrix, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:30 p.m., Eastern Time, on May 30, 2024, or as soon thereafter as practicable.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
| Very truly yours, | ||
| PULMATRIX, INC. | ||
| By: | /s/ Teofilo Raad | |
| Teofilo Raad | ||
| Chief Executive Officer and President | ||
cc: Rick A. Werner, Esq., Haynes and Boone, LLP